Literature DB >> 30180949

Deletion of PHGDH in adipocytes improves glucose intolerance in diet-induced obese mice.

Keisuke Okabe1, Isao Usui2, Keisuke Yaku3, Yoshio Hirabayashi4, Kazuyuki Tobe5, Takashi Nakagawa6.   

Abstract

Serine is a nonessential amino acid and plays an important role in cellular metabolism. In mammalian serine biosynthesis, 3-phosphoglycerate dehydrogenase (PHGDH) is considered a rate-limiting enzyme and is required for normal development. Although the biological functions of PHGHD in the nervous system have been intensively studied, its function in adipose tissue is unknown. In this study, we found that PHGDH is abundantly expressed in mature adipocytes of white adipose tissue. We generated an adipocyte-specific PHGDH knockout mouse (PHGDH FKO) and used it to investigate the role of serine biosynthesis in adipose tissues. Although PHGDH FKO mice had no apparent defects in adipose tissue development, these mice ameliorated glucose intolerance upon diet-induced obesity. Additionally, we found that the serine levels increase drastically in the adipose tissues of obese wild type mice, whereas no significant rise was observed in PHGDH FKO mice. Furthermore, wild type mice fed a serine-deficient diet also exhibited better glucose tolerance. These results suggest that PHGDH-mediated serine biosynthesis has important roles in adipose tissue glucose metabolism and could be a therapeutic target for diabetes in humans.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adipocyte; Glucose intolerance; Obesity; PHGDH; Serine

Mesh:

Substances:

Year:  2018        PMID: 30180949     DOI: 10.1016/j.bbrc.2018.08.180

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

1.  Renal UTX-PHGDH-serine axis regulates metabolic disorders in the kidney and liver.

Authors:  Hong Chen; Chong Liu; Qian Wang; Mingrui Xiong; Xia Zeng; Dong Yang; Yunhao Xie; Hua Su; Yu Zhang; Yixue Huang; Yuchen Chen; Junqiu Yue; Chengyu Liu; Shun Wang; Kun Huang; Ling Zheng
Journal:  Nat Commun       Date:  2022-07-04       Impact factor: 17.694

Review 2.  3-Phosphoglycerate dehydrogenase: a potential target for cancer treatment.

Authors:  Mingxue Li; Canrong Wu; Yueying Yang; Mengzhu Zheng; Silin Yu; Jinhui Wang; Lixia Chen; Hua Li
Journal:  Cell Oncol (Dordr)       Date:  2021-03-18       Impact factor: 6.730

3.  Proteome characteristics of liver tissue from patients with parenteral nutrition-associated liver disease.

Authors:  Gulisudumu Maitiabola; Feng Tian; Haifeng Sun; Li Zhang; Xuejin Gao; Bin Xue; Xinying Wang
Journal:  Nutr Metab (Lond)       Date:  2020-06-03       Impact factor: 4.169

4.  Epigenetic loci for blood pressure are associated with hypertensive target organ damage in older African Americans from the genetic epidemiology network of Arteriopathy (GENOA) study.

Authors:  Minjung Kho; Wei Zhao; Scott M Ratliff; Farah Ammous; Thomas H Mosley; Lulu Shang; Sharon L R Kardia; Xiang Zhou; Jennifer A Smith
Journal:  BMC Med Genomics       Date:  2020-09-11       Impact factor: 3.063

5.  PHGDH supports liver ceramide synthesis and sustains lipid homeostasis.

Authors:  Yun Pyo Kang; Aimee Falzone; Min Liu; Paloma González-Sánchez; Bo-Hyun Choi; Jonathan L Coloff; James J Saller; Florian A Karreth; Gina M DeNicola
Journal:  Cancer Metab       Date:  2020-06-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.